BRANCH COMPANY MACLEODS PHARMACEUTI — Levofloxacin Importer Profile
Pharmaceutical Importer · #7 buyer for Levofloxacin · $1.1M import value · 26 shipments · KAZAKISTAN · DGFT Verified
BRANCH COMPANY MACLEODS PHARMACEUTI is the #7 importer of Levofloxacin from India with $1.1M in import value and 26 verified shipments. BRANCH COMPANY MACLEODS PHARMACEUTI holds a 1.8% market share in Levofloxacin imports based in KAZAKISTAN. The company sources from 1 verified supplier across 11 formulations shipped to 2 countries.
BRANCH COMPANY MACLEODS PHARMACEUTI — Levofloxacin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Levofloxacin to BRANCH COMPANY MACLEODS PHARMACEUTI?
Verified from 26 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MACLEODS PHARMACEUTICALS LIMITED | $1.1M | 26 | 100.0% |
BRANCH COMPANY MACLEODS PHARMACEUTI sources Levofloxacin from 1 verified Indian supplier based on 26 customs records. The primary supplier is MACLEODS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does BRANCH COMPANY MACLEODS PHARMACEUTI Compare to Nearest Levofloxacin Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | MACLEODS PHARMACEUTICALS SA (PTY) | SOUTH AFRICA | $897.5K | 24 | $37.4K |
| 15 | DYVENPRO DISTRIBUCION Y VENTA DE | ECUADOR | $809.5K | 25 | $32.4K |
| 7 | BRANCH COMPANY MACLEODS PHARMACEUTI ★ | KAZAKHSTAN | $800.0K | 16 | $50.0K |
| 10 | LLC ?SENTISS RUS? | RUSSIA | $800.0K | 16 | $50.0K |
| 17 | E.P.DIS | FRANCE | $602.2K | 44 | $13.7K |
BRANCH COMPANY MACLEODS PHARMACEUTI ranks #7 among 1,543 Levofloxacin importers from India. Average shipment value of $50.0K compared to the market average of $9.1K. The closest competitors by value are MACLEODS PHARMACEUTICALS SA (PTY) and DYVENPRO DISTRIBUCION Y VENTA DE.
Where Does BRANCH COMPANY MACLEODS PHARMACEUTI Import Levofloxacin To?
Destination countries from 26 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| KAZAKISTAN | $812.4K | 20 | 73.0% |
| KAZAKHSTAN | $300.0K | 6 | 27.0% |
BRANCH COMPANY MACLEODS PHARMACEUTI imports Levofloxacin to 2 countries. The primary destination is KAZAKISTAN receiving 73.0% of shipments worth $812.4K.
What Levofloxacin Formulations Does BRANCH COMPANY MACLEODS PHARMACEUTI Import?
| Formulation | Value | Shipments |
|---|---|---|
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOMAC IV (LEVOFLOXACIN INFUSION 500 MG/100 ML ) | $300.0K | 6 |
| MEDICINES. LEVOFLOXACIN 500MG TABLETS(Ne | $200.0K | 4 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOMAC IV (LEVOFLOXACIN INFUSION 500 MG/100 ML) | $148.6K | 4 |
| LEVOMAC IV ( LEVOFLOXACIN INFUSION 500MG/ 100ML) BATCH: 23840118 MFG: 03/2024EXP: 02/2026 ( PACK 1 X 1) | $100.0K | 2 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOMAC IV (LEVOFLOXACIN INFUSION 500 MG/100 ML)NOS | $70.7K | 2 |
| LEVOFLOXACIN 500MG TABLETS 1X5'S (29800 PAC) NET CONTENT (LEVOFLOXACIN HEMIHYDRATE 74.5000 KGS) | $50.0K | 1 |
| LEVOMAC IV (LEVOFLOXACIN INFUSION 500MG/100ML) 1X1 BTL | $50.0K | 1 |
| LEVOMAC IV ( LEVOFLOXACIN INFUSION 500MG/ 100ML) BATCH: 23840119 MFG: 03/2024EXP: 02/2026 ( PACK 1 X 1) | $50.0K | 1 |
| LEVOMAC IV (LEVOFLOXACIN INFUSION 500MG/ 100ML) B: 23840118,119, 23840040 M: 03/24, 01/24 E:02/26, 12/25 (PACK 1 X 1) | $50.0K | 1 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOFLOXACIN TABLETS 500 MG | $50.0K | 1 |
BRANCH COMPANY MACLEODS PHARMACEUTI imports 11 distinct Levofloxacin formulations from India. The top formulation is DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOMAC IV (LEVO with 6 shipments worth $300.0K.
Who Are the Top Buyers of Levofloxacin from India and How Much Does BRANCH COMPANY MACLEODS PHARMACEUTI Import?
India exported $14.0M worth of Levofloxacin through 6,304 shipments from 699 suppliers to 150 countries, serving 1,543 buyers globally. BRANCH COMPANY MACLEODS PHARMACEUTI imports $1.1M of this total, accounting for 1.8% of India's Levofloxacin exports with 26 shipments from KAZAKISTAN. This is verified from 26 customs shipment records covering 11 distinct formulations.
What Is the Average Order Value for BRANCH COMPANY MACLEODS PHARMACEUTI's Levofloxacin Imports?
BRANCH COMPANY MACLEODS PHARMACEUTI's average Levofloxacin order value is $42.8K per consignment, based on 26 shipments totaling $1.1M. BRANCH COMPANY MACLEODS PHARMACEUTI is based in KAZAKISTAN and ranks #7 among all Levofloxacin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Levofloxacin to BRANCH COMPANY MACLEODS PHARMACEUTI?
BRANCH COMPANY MACLEODS PHARMACEUTI sources Levofloxacin from 1 verified Indian supplier: MACLEODS PHARMACEUTICALS LIMITED ($1.1M, 100.0%). This is based on 26 customs records.
How Does BRANCH COMPANY MACLEODS PHARMACEUTI Compare to Other Levofloxacin Importers?
BRANCH COMPANY MACLEODS PHARMACEUTI ranks #7 among 1,543 Levofloxacin importers from India with a 1.8% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($1.9M), LLC SENTISS RUS ($1.4M), FE ADVANCE PHARMACEUTICAL BUSINESS ($1.4M). BRANCH COMPANY MACLEODS PHARMACEUTI processed 26 shipments from KAZAKISTAN.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Levofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Levofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BRANCH COMPANY MACLEODS PHARMACEUTI matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BRANCH COMPANY MACLEODS PHARMACEUTI's capped import value divided by total capped export value for Levofloxacin across all Indian exporters.
- 5.Verified Records: This page is backed by 26 individual customs records matching BRANCH COMPANY MACLEODS PHARMACEUTI importing Levofloxacin, covering 11 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 1,543+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Levofloxacin Import Data for BRANCH COMPANY MACLEODS PHARMACEUTI
Access order-level details, pricing data, supplier connections, and competitive analysis for BRANCH COMPANY MACLEODS PHARMACEUTI's Levofloxacin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BRANCH COMPANY MACLEODS PHARMACEUTI
Company Profile
Multiple products · $0 total trade · Multiple categories
BRANCH COMPANY MACLEODS PHARMACEUTI × Levofloxacin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BRANCH COMPANY MACLEODS PHARMACEUTI.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levofloxacin. For current order-level data, contact TransData Nexus.